Intelligent Bio Solutions (INBS) Accumulated Expenses (2021 - 2025)

Intelligent Bio Solutions' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $534990.0 for Q2 2025.

• In Q2 2025, Accumulated Expenses rose 13.98% year-over-year to $534990.0; the TTM figure through Jun 2025 stood at $534990.0 (up 13.98% YoY), while the FY2025 annual figure was $534990.0, up 13.98% from the prior year.
• Accumulated Expenses was $534990.0 for Q2 2025 at Intelligent Bio Solutions, up from $447670.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $660010.0 in Q1 2024 to a low of $102475.0 in Q2 2021.
• Historically, Accumulated Expenses has averaged $344976.2 across 5 years, with a median of $366893.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses jumped 139.5% in 2022, then tumbled 32.17% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $129212.0 in 2021, then surged by 139.5% to $309469.0 in 2022, then increased by 18.56% to $366893.0 in 2023, then advanced by 13.64% to $416929.0 in 2024, then gained by 28.32% to $534990.0 in 2025.
• The last three Accumulated Expenses figures came in at $534990.0 (Q2 2025), $447670.0 (Q1 2025), and $416929.0 (Q4 2024), per Business Quant data.